Screener
Biogen BIIB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Biogen in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Biogen’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:36 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000875045-26-000075
FAQ
- What is Biogen's accrued expenses?
- Biogen (BIIB) reported accrued expenses of $391.3M in Q2 2026.
- How has Biogen's accrued expenses changed year-over-year?
- Biogen's accrued expenses increased by 50.0% year-over-year, from $260.9M to $391.3M.
- What is the long-term trend for Biogen's accrued expenses?
- Over 5 years (2020 to 2025), Biogen's accrued expenses has grown at a -2.3% compound annual growth rate (CAGR), from $3.15B to $2.8B.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Biogen's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude